Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
Titel:
Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
Auteur:
Waddell, T. Gollins, S. Soe, W. Valle, J. Allen, J. Bentley, D. Morris, J. Lloyd, A. Swindell, R. Taylor, M. B. Saunders, M. P.